Insider Transactions in Q3 2023 at Becton Dickinson & CO (BDX)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 07
2023
|
Christopher Del Orefice EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
601
-5.18%
|
-
|
|
Sep 05
2023
|
Richard Byrd EVP & President Interventional |
SELL
Open market or private sale
|
Direct |
459
-11.76%
|
$125,766
$274.48 P/Share
|
|
Sep 01
2023
|
Richard Byrd EVP & President Interventional |
SELL
Payment of exercise price or tax liability
|
Direct |
216
-5.24%
|
-
|
|
Sep 01
2023
|
Christopher Del Orefice EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
353
-2.95%
|
-
|
|
Aug 28
2023
|
Claire Fraser Director |
SELL
Open market or private sale
|
Direct |
848
-3.78%
|
$238,288
$281.66 P/Share
|
|
Aug 11
2023
|
David Hickey EVP & President, Life Sciences |
SELL
Open market or private sale
|
Direct |
2,974
-41.46%
|
$823,798
$277.85 P/Share
|
|
Aug 11
2023
|
David Hickey EVP & President, Life Sciences |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,857
-20.56%
|
$514,389
$277.85 P/Share
|
|
Aug 11
2023
|
David Hickey EVP & President, Life Sciences |
BUY
Exercise of conversion of derivative security
|
Direct |
3,883
+30.07%
|
$512,556
$132.54 P/Share
|
|
Aug 08
2023
|
Michael David Garrison EVP & President Medical |
SELL
Open market or private sale
|
Direct |
1,300
-20.13%
|
$360,100
$277.13 P/Share
|
|
Jul 24
2023
|
Joanne Waldstreicher Director |
BUY
Grant, award, or other acquisition
|
Direct |
419
+50.0%
|
-
|
|
Jul 01
2023
|
Thomas J Spoerel SVPController & Chief Acct Off |
SELL
Grant, award, or other acquisition
|
Direct |
47
-2.51%
|
-
|